All News #Library
Biotech
Advanz Pharma Launches Alvotech`s Simponi Biosimilar Across
22 Dec 2025 //
GLOBENEWSWIRE
Alvotech, Advanz Pharma Gain EMA Nod for Gobivaz
20 Nov 2025 //
PHARMIWEB
Alvotech, Advanz Pharma Secure MHRA Approval For Gobivaz
06 Nov 2025 //
GLOBENEWSWIRE
EMA Accepts AVT23 Xolair Biosimilar Application From Alvotech
06 Oct 2025 //
GLOBENEWSWIRE
European Medicines Agency Backs Gobivaz® Approval As Simponi®
22 Sep 2025 //
GLOBENEWSWIRE
Advanz Pharma, Alvotech Get EU Approval for Mynzepli
21 Aug 2025 //
GLOBENEWSWIRE
Advanz Pharma & Alvotech Win European Approval for Mynzepli
21 Aug 2025 //
CONTRACTPHARMA
Alvotech and Advanz Pharma Partner for Biosimilar to Cimzia®
01 Jul 2025 //
GLOBENEWSWIRE
Positive Results from Efficacy Study for Biosimilar to Xolair®
25 Jun 2025 //
GLOBENEWSWIRE
Alvotech, Advanz Pharma Extend Partnership for 3 More Biosimilars
28 May 2025 //
GLOBENEWSWIRE
EMA Accepts Marketing Application for AVT05 Biosimilar to Simponi®
04 Nov 2024 //
GLOBENEWSWIRE
Alvotech & Advanz announce commercialisation agreement for Eylea biosimilar
18 Jun 2024 //
PHARMAFILE
Alvotech Enters Into Commercialization Agreement With Advanz Pharma for Xolair
06 Feb 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support